ACHV
|
Achieve Life Sciences, Inc.
|
US
|
NASDAQ
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
BCTX
|
BriaCell Therapeutics Corp.
|
US
|
NASDAQ
|
BIOC
|
Biocept, Inc.
|
US
|
NASDAQ
|
BPTH
|
Bio-Path Holdings Inc
|
US
|
NASDAQ
|
CHRS
|
Coherus BioSciences, Inc.
|
US
|
NASDAQ
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
CLVS
|
Clovis Oncology, Inc.
|
US
|
NASDAQ
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
CTIC
|
Cell Therapeutics, Inc.
|
US
|
NASDAQ
|
GLSI
|
Greenwich LifeSciences, Inc.
|
US
|
NASDAQ
|
GTHX
|
G1 Therapeutics, Inc.
|
US
|
NASDAQ
|
HOLX
|
Hologic, Inc.
|
US
|
NASDAQ
|
ICAD
|
icad inc.
|
US
|
NASDAQ
|
IMGN
|
ImmunoGen, Inc.
|
US
|
NASDAQ
|
ISR
|
IsoRay, Inc.
|
US
|
AMEX
|
MACK
|
Merrimack Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
NKTR
|
Nektar Therapeutics
|
US
|
NASDAQ
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
US
|
NASDAQ
|